You are here: All Products  > Harbour Biomed to Start US Trials of Novel B7H7 Immunoncology Asset

Harbour Biomed to Start US Trials of Novel B7H7 Immunoncology Asset

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products